No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Amplia Therapeutics Completes Enrollment for Phase 2A Pancreatic Cancer Trial; Shares Up 3%
Amplia Therapeutics Hits Key Trial Milestone
Amplia Therapeutics Ltd: Preliminary Final Report and Annual Report YE 31 March 2024
Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing
Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II
Amplia Therapeutics Updates on Pancreatic Cancer Trial; Phase-Two Recruitment Ongoing; Shares Up 3%
No Data